La reducción de daños y los derechos humanos en el contexto del nuevo modelo de financiación del Fondo Mundial
El pasado septiembre, el Foro Mundial sobre HSH y VIH y la Red INPUD presentaron un seminario web sobre estrategias para abordar la reducción de daños y los derechos humanos en el contexto del nuevo modelo de financiación del Fondo Mundial. Más información, en inglés, está disponible abajo.
Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.
Recording available here
On September 10, 2014, the Global Forum on MSM & HIV (MSMGF) and the International Network of People who Use Drugs (INPUD) presented a webinar on strategies for addressing harm reduction and human rights in the context of the Global Fund’s New Funding Model (NFM).
The Global Fund has historically been the largest multilateral donor to harm reduction programming and has committed to supporting programming for people who inject drugs. However, crucial funding decisions taken at the most recent Global Fund Board meeting have meant that most of the countries with the largest epidemics amongst people who inject drugs are no longer eligible for funding, being classified as middle income countries. In addition, the governments of most of these countries have shown a clear reluctance to pay for harm reduction programmes themselves. This poses serious risks for the global response to HIV amongst people who inject drugs. Given that one in three new infections outside of Sub-Saharan Africa take place within this community, this also jeopardises an effective response to the epidemic in general.
This webinar featured a discussion of INPUD's experiences conducting harm reduction and drug user organising work in Kenya and Tanzania, as well as information on connecting harm reduction efforts and human rights. The Global Fund’s NFM and the harm reduction information note produced by the Global Fund were also presented for discussion.
Recordings of this and past MSMGF webinars can be found on the MSMGF website. Any questions can be directed toc ontact@msmgf.org.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.